Pharmalittle: Pfizer pays $636 million for rights to gene therapies; Novartis denies bribing Greek officials

Top of the morning to you. Another busy day is unfolding here on the Pharmalot campus, where we are mulling over our cluttered calendar and plotting our next moves. No doubt, you can relate. After all ...

READ THE ORIGINAL POST AT www.statnews.com